TrialInternational journal of hematology2006

Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease.

Akiyoshi Takami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.